This study investigates pancreatic cancer with liver metastases. It focuses on evaluating a specific treatment approach for this condition.
The study evaluates the safety and effectiveness of combining an investigational medication with an AG regimen. The investigational medication is being examined to see how well it works and how safe it is for patients.
- Who can participate: Adults aged 18 to 75 can participate. Participants should have good physical strength.
- Study details: Participants will receive an investigational medication combined with AG regimen. The study will measure safety and effectiveness.